CTI BioPharma
38 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects (NCT05657613) | CTI BioPharma | 2023-01-03 |
| Study to Evaluate the Safety, Tolerability, and PK of Pacritinib (NCT05552183) | CTI BioPharma | 2022-12-12 |
Track CTI BioPharma automatically
Every clearance here is in the API, with alerts when new ones post.